Beyond Dissolution. Before Animals. Introducing a Biorelevant In Vitro Approach to Subcutaneous Drug Testing

Beyond Dissolution. Before Animals. Discover how SCISSOR N3™, Pion’s biorelevant in vitro platform, can provide insights into subcutaneous drug release, depot formation, and stability in a controlled laboratory setting. Through real-world case studies, learn how SCISSOR can support formulation selection earlier in development, bridge the gap between benchtop testing and animal studies, and help reduce development risk and animal usage.

Learn how to: Evaluate subcutaneous formulations, assess critical attributes, and apply biorelevant testing across biologics, peptides, long-acting injectables, and in situ forming gels.

‍